Can FIP Be Mistaken for Liver Disease

Abstract

Feline Infectious Peritonitis (FIP), a devastating viral illness in cats, remains a diagnostic challenge even for experienced veterinarians. The clinical manifestations of FIP often overlap with other diseases—including hepatic disorders—leading to frequent misdiagnosis or delayed diagnosis. This article explores how and why FIP can be mistaken for liver disease and provides guidance for differentiating between these conditions, drawing upon recent research, clinical experience, and diagnostic advancements.

Introduction

Feline Infectious Peritonitis is induced by feline coronavirus (FCoV) mutations and is most common in young cats, especially those in multicat environments. Its presentation is variable, ranging from “dry” (non-effusive) to “wet” (effusive) forms, with systemic involvement and signs that mimic numerous other ailments. On the other hand, feline liver disease encompasses a spectrum—hepatitis, hepatic lipidosis, cholangiohepatitis—with symptoms that can resemble FIP. Deciphering between FIP and hepatic pathology demands careful evaluation of clinical, laboratory, imaging, and histopathological findings.

Clinical Presentation Overlaps

Both FIP and liver disease can trigger systemic signs—lethargy, inappetence, weight loss, vomiting, and jaundice. Effusive FIP, which causes fluid accumulation in the abdomen or chest, frequently masquerades as hepatic ascites. Non-effusive FIP often manifests as chronic fever, weight loss, and occasional icterus, mirroring symptoms in cats with hepatic dysfunction. Icterus (yellowing of mucous membranes and sclera), a classic indication of hepatic distress, is also seen in FIP due to liver infiltration by granulomatous lesions or secondary hemolysis. Other overlapping signs such as diarrhea, hypoproteinemia, and behavioral changes further confound clinical distinction.

Pathophysiological Basis for Confusion

FIP causes multisystemic vasculitis—chronic inflammation of small blood vessels—which frequently affects the liver. Granulomatous hepatitis, seen in FIP, results from viral replication in macrophages within hepatic tissue. These inflammatory foci disrupt liver function, mimicking primary hepatic diseases both biochemically and structurally. Meanwhile, hepatic diseases may induce secondary systemic signs (fever, effusions, neurological deficits) due to impaired protein synthesis, detoxification, and coagulation function, which are indistinguishable from advanced FIP.

Diagnostic Imaging Challenges

Ultrasound and radiography play a vital role in diagnosis but cannot reliably distinguish between FIP and liver disease. Cats with FIP often present with hepatomegaly, abdominal fluid, and altered echogenicity—all shared with hepatic lipidosis, neoplasia, or cholangiohepatitis. Imaging rarely reveals the underlying etiological agent, necessitating further laboratory and cytological tests.

Laboratory Test Considerations

Routine laboratory tests (complete blood count, blood chemistry, urinalysis) show overlapping features in both conditions. Anemia, lymphopenia, hyperglobulinemia, and hypoalbuminemia are seen in FIP and hepatic diseases. Elevations of hepatic enzymes (ALT, AST, ALP, GGT), hyperbilirubinemia, and altered bile acids profiles lack specificity. Even advanced tests like FCoV antibody titers may only suggest exposure, not confirmation of FIP. The gold standard for FIP diagnosis involves immunohistochemistry or PCR detection of FCoV within affected tissues; however, ante-mortem liver biopsies carry risks and may not always be feasible.

Ascitic Fluid Analysis

Effusions from FIP and hepatic disease exhibit similarities. Both can present as straw-colored, protein-rich fluids. Fluid cytology, protein concentration, and Rivalta tests help distinguish exudates from transudates and narrow differential diagnoses. A positive Rivalta test supports FIP but is not definitive. The identification of high-protein, low-cellularity exudates is commonly seen in FIP, but similar patterns arise from severe hepatic insufficiency or neoplasia with portal hypertension.

Histopathological Distinctions

Histological examination remains one of the most reliable methods in differentiating FIP from liver disease. The presence of pyogranulomatous vasculitis involving the liver and peritoneum strongly suggests FIP, while hepatic disease more commonly reveals necrosis, fatty infiltration (lipidosis), or lymphocytic infiltration in primary hepatic processes. Immunohistochemistry detecting FCoV antigens within tissue macrophages confirms the diagnosis, but sampling affected hepatic lesions safely and accurately continues to be a challenge in clinical practice.

Treatment Implications of Misdiagnosis

Accurate and timely differentiation affects management and prognosis. FIP historically carried a grave prognosis; recent breakthroughs (GS-441524, remdesivir) offer hope for selected cases, but immunosuppressants used for hepatic disease may accelerate FIP progression. Conversely, misidentifying hepatic diseases as FIP may lead to withholding potentially lifesaving treatments for conditions like hepatic lipidosis or infectious hepatitis.

Epidemiological Considerations

Populations at risk differ slightly; FIP is more frequent in cats under three years, especially in multi-cat households and shelters. Liver disease affects cats of all ages, often secondary to other stresses. Cluster outbreaks of FIP, reported in catteries or shelters, often prompt broader diagnostic screening for hepatic parameters due to overlapping signs.

Advances in Diagnostic Strategies

Novel diagnostics aim to improve early differentiation: molecular tests (RT-PCR for FCoV RNA in tissues/effusions), advanced imaging (contrast-enhanced ultrasound, elastography), and the use of biomarker panels (alpha-1 acid glycoprotein, soluble interleukin-2 receptor) are showing promise. These tests, while increasing specificity, must be interpreted in the context of clinical presentation and risk factors to avoid mistaken identity.

Clinical Algorithms for Distinction

Veterinarians rely on stepwise diagnostic algorithms. Initial presentation prompts bloodwork and imaging, followed by effusion analysis in cases with ascites. Advanced tests and tissue biopsies confirm etiology. Decision-making trees accounting for age, risk group, presenting symptoms, ancillary findings, and access to advanced tests optimize the diagnostic process.

Owner and Practitioner Communication

For pet owners, the distinction between FIP and liver disease can be life-altering. Clear communication regarding diagnostic limitations, prognosis, and evolving treatments is crucial. Education about the nature of FIP and its overlap with hepatic diseases empowers owners in decision-making and expectations management.

Conclusion

Recognizing that FIP can easily be mistaken for liver disease underscores the complexity of feline medicine. Clinical overlap is extensive, diagnostic tools are imperfect, and a multidisciplinary approach is essential. Improved awareness, advanced diagnostics, and ongoing research continue to refine our understanding, ultimately leading to more accurate diagnoses and better outcomes for cats.

References

1. Addie, D.D., et al. Feline infectious peritonitis: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery. 2021;23(6):529–541.

2. Tasker, S. Diagnosis of feline infectious peritonitis: Update on evidence supporting laboratory tests. Journal of Feline Medicine and Surgery. 2018;20(3):228–243.

3. Hartmann, K. Feline infectious peritonitis. Veterinary Clinics of North America: Small Animal Practice. 2005;35(1):39–79.

4. Rissi, D.R. A retrospective study of the pathology and immunohistochemistry of feline infectious peritonitis in cats in the United States. Veterinary Pathology. 2018;55(6):872–884.

5. Giordano, C., et al. Hepatic lesions in cats with feline infectious peritonitis: A histopathological and immunohistochemical study. Veterinary Immunology and Immunopathology. 2005;108(1-2):17–28.

6. Kipar, A., et al. Feline infectious peritonitis: Still an enigma? Journal of Comparative Pathology. 2005;135(3):180–192.

7. Felten, S., et al. Diagnostic challenges in feline infectious peritonitis: A review of laboratory and imaging findings. Veterinary Quarterly. 2017;37(1):27–43.

8. Tennant, B.C. Hepatic diseases in cats. Veterinary Clinics of North America: Small Animal Practice. 1993;23(2):257–285.

9. Norris, J.M. et al. Feline infectious peritonitis: New developments and diagnostics. Australian Veterinary Journal. 2022;100(2):40–49.

10. Pedersen, N.C. Feline infectious peritonitis—Something old, something new. Feline Medicine and Surgery. 2020;22(11):913–926.